Management of corticosteroid-induced osteoporosis
- 1 October 1998
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 352 (9137) , 1327-1328
- https://doi.org/10.1016/s0140-6736(05)60740-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an updateJournal of Internal Medicine, 1998
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1998
- Randomized Trial of Effect of Cyclical Etidronate in the Prevention of Corticosteroid-Induced Bone LossJournal of Clinical Endocrinology & Metabolism, 1998
- Prevention of Corticosteroid-Induced Osteoporosis with Alendronate in Sarcoid PatientsCalcified Tissue International, 1997
- Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced OsteoporosisNew England Journal of Medicine, 1997
- Users of low-dose glucocorticoids have increased bone loss rates: A longitudinal studyCalcified Tissue International, 1995
- Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroidsArthritis & Rheumatism, 1994
- Corticosteroid effects on proximal femur bone lossJournal of Bone and Mineral Research, 1990
- Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosisCalcified Tissue International, 1983
- Steroid-Induced Fractures and Bone Loss in Patients with AsthmaNew England Journal of Medicine, 1983